A genomewide association study of citalopram response in major depressive disorder-A psychometric approach

Biological Psychiatry

Volumn 68, Issue 6, 2010, Pages

  Adkins, Daniel E ^a   Berg, Karolina ^a   McClay, Joseph L ^a   Hettema, John M ^b   Kornstein, Susan G ^b   Bukszr, Jzsef ^a   Van Den Oord, Edwin J C G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

CLINICAL FEATURE; DRUG DOSE REDUCTION; GENOME ANALYSIS; HUMAN; INTRON; LETTER; MAJOR DEPRESSION; PRIORITY JOURNAL; PSYCHOMETRY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMETRICS;

EID: 77956175934     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.05.018     Document Type: Letter

References (16)

1. H.A. Garriock, J.B. Kraft, S.I. Shyn, E.J. Peters, J.S. Yokoyama, and G.D. Jenkins A genomewide association study of citalopram response in major depressive disorder Biol Psychiatry 67 2010 133 138
2. R.C. MacCallum, S.B. Zhang, K.J. Preacher, and D.D. Rucker On the practice of dichotomization of quantitative variables Psychol Methods 7 2002 19 40
3. J. Cohen The cost of dichotomization Appl Psych Meas 7 1983 249 253
4. J.B. Willett Some results on reliability for the longitudinal measurement of changeimplications for the design of studies of individual growth Educ Psychol Meas 49 1989 587 602
5. J.B. Willett, J.D. Singer, and N.C. Martin The design and analysis of longitudinal studies of development and psychopathology in context: Statistical models and methodological recommendations Dev Psychopathol 10 1998 395 426
6. K.A. Bollen Structural Equations with Latent Variables 1989 Wiley New York
7. A.J. Rush, M. Fava, S.R. Wisniewski, P.W. Lavori, M.H. Trivedi, and H.A. Sackeim Sequenced treatment alternatives to relieve depression (STAR (*)D): Rationale and design Control Clin Trials 25 2004 119 142
8. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A.R. Ferreira, and D. Bender PLINK: A tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
9. E.J. van den Oord, D.E. Adkins, J. McClay, J. Lieberman, and P.F. Sullivan A systematic method for estimating individual responses to treatment with antipsychotics in CATIE Schizophr Res 107 2009 13 21
10. D.E. Adkins, K. Aberg, J.L. McClay, J. Bukszar, Z. Zhao, and P. Jia Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs [published online ahead of print March 2] Mol Psychiatry 2010
11. A. Tylee, and P. Walters Onset of action of antidepressants BMJ 334 2007 911 912
12. M.J. Taylor, N. Freemantle, J.R. Geddes, and Z. Bhagwagar Early onset of selective serotonin reuptake inhibitor antidepressant actionsystematic review and meta-analysis Arch Gen Psychiatry 63 2006 1217 1223
13. G.K. Robinson That BLUP is a good thing: The estimation of random effects Stat Sci 6 1991 15 32
14. E. van den Oord, and P.F. Sullivan False discoveries and models for gene discovery Trends Genet 19 2003 537 542
15. J.D. Storey, and R. Tibshirani Statistical significance for genomewide studies Proc Natl Acad Sci U S A 100 2003 9440 9445
16. J. Yao, Y. Liu, J. Husain, R. Lo, A. Palaparti, J. Henderson, and S. Stifani Combinatorial expression patterns of individual TLE proteins during cell determination and differentiation suggest non-redundant functions for mammalian homologs of Drosophila groucho Dev Growth Differ 40 1998 133 146